The Top 4 Stocks to Short as Rates Continue to Rise

With higher interest expenses, companies such as Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) may be the best short sell available.

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Whenever a change in interest rates takes place, it is normal for businesses and consumers to adjust how long-term purchases are financed. On the one side are borrowers — consumers and businesses who pay interest (now at a higher rate) — while on the other side are the lending institutions now loaning money at higher interest rates.

The result of higher interest rates is a higher cost to borrow for the borrower and a higher amount of revenue for the lender. Moving forward, there are certain companies that may be able to weather the storm better than others. Let’s look those that may have a more difficult time with the higher rates.

Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has close to US$28 billion in debt, which is being repaid at a snail’s pace. In addition to increasing interest rates, the company has been forced to sell a number of revenue-generating assets, thereby reducing future revenues. Although the rising interest rates will act as a headwind for the company, the business risk is also a major factor.

For investors who’d sought out an investment that produced ongoing income, shares of Enbridge Inc. (TSX:ENB)(NYSE:ENB) may have hit a peak for years to come. Enbridge has seen revenues move sideways, while the amount of long-term debt has increased. In the past fiscal year, the dividend-payout ratio was no less than 84%, as the total amount of shareholders’ equity declined by almost $3 billion over the first half of this year. A 1% increase in rates will add more than $600 million in interest expenses.

Given that the company made a total profit of $2.07 billion in fiscal 2016, any significant increase in interest rates will have a significant impact on its ability to deliver shareholder value and could potentially put the dividend at risk.

Another Canadian giant that is vulnerable to increasing interest rates is Teck Resources Ltd. (TSX:TECK.B)(NYSE:TECK), which carries long-term debt of $6.3 billion. Given that the company’s profits were only $1 billion in fiscal 2016 and it had a loss of $2.5 billion the year before, both liquidity and solvency can become concerns very quickly should the company fail to see a pickup in resource prices.

Last up is Bombardier, Inc. (TSX:BBD.B), which is a major short sell for different reasons. Given that the company manufactures rail cars, the long-term nature of its business means that a buyer’s ability to finance the purchase is crucial. With more companies and cities feeling strapped for cash, the headwinds felt by the Quebec-based company will only increase over time.

Currently, the company’s balance sheet is not in great shape as total liabilities are close to $29 billion and total assets fall very short, coming in at $23.4 billion.

As rates have remained low for close to a decade, many companies have taken advantage by altering the capital structure to include more debt and less equity. As low interest rates are expected to reverse over time, investors may be wise to position themselves accordingly.

Should you invest $1,000 in Bausch Health Companies right now?

Before you buy stock in Bausch Health Companies, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Bausch Health Companies wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $20,697.16!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 29 percentage points since 2013*.

See the Top Stocks * Returns as of 3/20/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Ryan Goldsman has no position in any stocks mentioned. Tom Gardner owns shares of Valeant Pharmaceuticals. The Motley Fool owns shares of Enbridge and Valeant Pharmaceuticals. Enbridge is a recommendation of Stock Advisor Canada.

Confidently Navigate Market Volatility: Claim Your Free Report!

Feeling uneasy about the ups and downs of the stock market lately? You’re not alone. At The Motley Fool Canada, we get it — and we’re here to help. We’ve crafted an essential guide designed to help you through these uncertain times: "5-Step Checklist: How to Prepare Your Portfolio for Volatility."

Don't miss out on this opportunity for peace of mind. Just click below to learn how to receive your complimentary report today!

Get Our Free Report Today

More on Investing

A meter measures energy use.
Dividend Stocks

Top Canadian Utility Stocks for Stability in 2025

In addition to attractive dividend income, these Canadian utility stocks can help investors see their invested money grow over time.

Read more »

sale discount best price
Dividend Stocks

2 Canadian Dividend Giants Trading at Bargain Prices After Market Dip

North West Company (TSX:NWC) stock looks like a dividend bargain for those looking to play defence.

Read more »

A worker gives a business presentation.
Investing

Kinaxis (TSX:KXS) Is Below $160: Buy Now?

Kinaxis (TSX:KXS) stock is trading at significantly lower levels than its 52-week high and it might be a good opportunity…

Read more »

Man data analyze
Tech Stocks

Where Will Constellation Software Stock Be in 10 Years?

It's wild to think that one of the safest stocks out there is this tech stock, but here we are,…

Read more »

Oil industry worker works in oilfield
Energy Stocks

Are Canadian Energy Stocks a Good Buy Right Now?

Buying the dip sure yields results. However, are Canadian energy stocks a buy at the dip amid the tariff war?

Read more »

Hand Protecting Senior Couple
Dividend Stocks

Here’s How Many Shares of Sienna Senior Living You Should Own to Get $500 in Monthly Dividends

While earning monthly passive income from Canadian dividend stocks is easy, investors must focus on portfolio diversification to minimize the…

Read more »

ETF chart stocks
Investing

Buy Canadian: 3 ETFs to Keep Your Money at Home

These three BMO ETFs focus on Canadian stocks.

Read more »

Canadian dollars are printed
Dividend Stocks

Transform Your TFSA Into a Cash-Gushing Machine With Just $20,000

Holding undervalued dividend stocks in a TFSA should help you deliver outsized capital gains and a steady stream of passive…

Read more »